Hfmref - Open Access .click

Results 141 to 150 of about 4,764 (176)

Some of the next articles are maybe not open access.

Prognosis of left ventricular dilatation in HFmrEF

European Heart Journal
Abstract Background Left ventricular (LV) dilatation reflects adverse remodeling in heart failure with mildly reduced ejection fraction (HFmrEF), but its prognostic role remains uncertain. Methods In this analysis, 2 ...
T Schupp +8 more
openaire +1 more source

Serum proteomic signatures of atrial fibrillation in HFpEF/HFmrEF

European Journal of Heart Failure
Abstract Background Atrial fibrillation (AF) frequently complicates the clinical course of patients with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF), yet the underlying molecular mechanisms extend far beyond electrical atrial remodelling.
J Vogel +9 more
openaire +1 more source

Dapagliflozin improves outcomes in HFmrEF and HFpEF

Nature Reviews Cardiology, 2022
openaire +2 more sources

Dapagliflozin DELIVERs for HFmrEF/HFpEF

Medicom Conference Report ESC 2022, 2022
openaire +1 more source

Risk Factors of Short-Term, Intermediate-Term, and Long-Term Cardiac Events in Patients Hospitalized for HFmrEF

ESC Heart Failure, 2022
Jianping Zeng, Yunlong Zhu, Na Li
exaly

Who wants the middle seat?: HFmrEF in a world dominated by HFpEF and HFrEF

Journal of Cardiac Failure, 2023
Peter M, Eckman, Ruben, Crespo
openaire +2 more sources

Ejection fraction at hospital admission stratifies mortality risk in HFmrEF patients aged ≥ 70 years: a retrospective analysis from a tertiary university institution

Aging Clinical and Experimental Research, 2023
Andrea Sonaglioni, Sérgio Harari
exaly

Effects of sacubitril/valsartan on clinical symptoms, echocardiographic parameters, and outcomes in HFrEF and HFmrEF patients with coronary heart disease and chronic kidney disease

Current Medical Research and Opinion, 2021
Dongjian Han +2 more
exaly